Bhagiradha Chemicals & Industries Limited — Others, 28-05-2025: Statement of deviation(s) or variation(s) under Reg. 32

Bhagiradha Chemicals and Industries has announced a board meeting on the financial results for the quarter and half-year. The company reports no deviation in the use of proceeds from its Rs. 341.18 Cr preferential issue of convertible warrants. Most funds have been invested in capital expenditure for a new manufacturing unit through its wholly owned subsidiary, Bheema Fine Chemicals, in Karnataka, covering construction and machinery. Rs. 21.18 Cr is earmarked for working capital after project commissioning, with interim funds placed in secure money market instruments and deposits.